The Latin America, Middle East and Africa Vascular Access Device Market should witness market growth of 9.0% CAGR during the forecast period (2023-2030).
The design of devices will be revolutionized by nanotechnology and biocompatible materials, enabling better physiological integration and reducing complications. Additionally, smart VADs fitted with sensor technology will make real-time monitoring and data analysis possible, enabling medical personnel to respond quickly and with information. These developments will put the market at the forefront of medical innovation in the upcoming years while improving patient outcomes and streamlining healthcare delivery.
Vascular access devices are being used increasingly for ambulatory care. They relieve pressure on hospitals while providing patients with a practical and efficient way to get care in the privacy of their own homes. To ensure the proper use and effectiveness of the device, regular follow-up appointments and thorough training for patients and caregivers in using and maintaining these devices are necessary. These tools are crucial in helping patients live better lives and providing medication more easily and effectively.
The estimated cancer burden in AFRO countries is mostly due to breast cancer, which accounts for 16.8% of all cancer cases, trailed by cervical cancer, which accounts for 10.6% of all cases. When taken as a whole, this is the most prevalent in African girls. Prostate cancer was the most frequent cancer in African men, accounting for 19.6% of all cases, followed by liver cancer (9.5% of all cases). Rising cancer frequency in emerging nations in this region and increased awareness regarding vascular access devices in diagnostics are expected to fuel market expansion in the region over the forecast period.
The Brazil market dominated the LAMEA Vascular Access Device Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $171.1 million by 2030. The Argentina market is showcasing a CAGR of 9.6% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.7% during (2023-2030).
Based on Application, the market is segmented into Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing. Based on End-user, the market is segmented into Hospital, Clinics & Ambulatory Care Centers and Others. Based on Type, the market is segmented into Central Vascular Access Device (Tunneled Catheters, Peripherally Inserted Central Catheters, Non-tunneled Catheters, and Implanted Ports), Peripheral Vascular Access Device (Peripheral Midlines Devices, Peripheral Short Devices and Butterfly/winged Steel Needles) and Accessories. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ICU Medical, Inc., Teleflex, Inc., B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Edwards Lifesciences Corporation, Nipro Corporation and Romsons.
The design of devices will be revolutionized by nanotechnology and biocompatible materials, enabling better physiological integration and reducing complications. Additionally, smart VADs fitted with sensor technology will make real-time monitoring and data analysis possible, enabling medical personnel to respond quickly and with information. These developments will put the market at the forefront of medical innovation in the upcoming years while improving patient outcomes and streamlining healthcare delivery.
Vascular access devices are being used increasingly for ambulatory care. They relieve pressure on hospitals while providing patients with a practical and efficient way to get care in the privacy of their own homes. To ensure the proper use and effectiveness of the device, regular follow-up appointments and thorough training for patients and caregivers in using and maintaining these devices are necessary. These tools are crucial in helping patients live better lives and providing medication more easily and effectively.
The estimated cancer burden in AFRO countries is mostly due to breast cancer, which accounts for 16.8% of all cancer cases, trailed by cervical cancer, which accounts for 10.6% of all cases. When taken as a whole, this is the most prevalent in African girls. Prostate cancer was the most frequent cancer in African men, accounting for 19.6% of all cases, followed by liver cancer (9.5% of all cases). Rising cancer frequency in emerging nations in this region and increased awareness regarding vascular access devices in diagnostics are expected to fuel market expansion in the region over the forecast period.
The Brazil market dominated the LAMEA Vascular Access Device Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $171.1 million by 2030. The Argentina market is showcasing a CAGR of 9.6% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.7% during (2023-2030).
Based on Application, the market is segmented into Drug Administration, Fluid & Nutrition Administration, Blood Transfusion and Diagnostics & Testing. Based on End-user, the market is segmented into Hospital, Clinics & Ambulatory Care Centers and Others. Based on Type, the market is segmented into Central Vascular Access Device (Tunneled Catheters, Peripherally Inserted Central Catheters, Non-tunneled Catheters, and Implanted Ports), Peripheral Vascular Access Device (Peripheral Midlines Devices, Peripheral Short Devices and Butterfly/winged Steel Needles) and Accessories. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ICU Medical, Inc., Teleflex, Inc., B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Edwards Lifesciences Corporation, Nipro Corporation and Romsons.
Scope of the Study
By Application
- Drug Administration
- Fluid & Nutrition Administration
- Blood Transfusion
- Diagnostics & Testing
By End-user
- Hospital
- Clinics & Ambulatory Care Centers
- Others
By Type
- Central Vascular Access Device
- Tunneled Catheters
- Peripherally Inserted Central Catheters
- Non-tunneled Catheters
- Implanted Ports
- Peripheral Vascular Access Device
- Peripheral Midlines Devices
- Peripheral Short Devices
- Butterfly/winged Steel Needles
- Accessories
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- ICU Medical, Inc.
- Teleflex, Inc.
- B.Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Nipro Corporation
- Romsons
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Vascular Access Device Market by Application
Chapter 6. LAMEA Vascular Access Device Market by End User
Chapter 7. LAMEA Vascular Access Device Market by Type
Chapter 8. LAMEA Vascular Access Device Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- ICU Medical, Inc.
- Teleflex, Inc.
- B. Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Becton, Dickinson and Company
- AngioDynamics, Inc.
- Edwards Lifesciences Corporation
- Nipro Corporation
- Romsons
Methodology
LOADING...
